| Literature DB >> 25101264 |
Michal Zabrodsky1, Petr Lukes1, Eva Lukesova1, Jan Boucek1, Jan Plzak1.
Abstract
Narrow band imaging is considered a significant improvement in the possibility of detecting early mucosal lesion of the upper aerodigestive tract. Early detection of mucosal neoplastic lesions is of utmost importance for patients survival. There is evidence that, especially in patients previously treated by means of curative radiotherapy or chemoradiotherapy, the early detection rate of recurrent disease is quite low. The aim of this study was to prove whether the videoendoscopy coupled with NBI might help detect recurrent or secondary tumors of the upper aerodigestive tract. 66 patients previously treated by means of RT or CRT with curative intent were enrolled in the study. All patients underwent transnasal flexible videoendoscopy with NBI mode under local anesthesia. When a suspicious lesion was identified in an ambulatory setting, its nature was proved histologically. Many of these changes were not identifiable by means of conventional white light (WL) endoscopy. The accuracy, sensitivity, specificity, and positive and negative predictive value of the method are very high (88%, 92%, 76%, 96%, and 91%, resp.). Results demonstrate that outpatient transnasal endoscopy with NBI is an excellent method for the follow-up of patients with carcinomas of the larynx and the hypopharynx primarily treated with radiotherapy.Entities:
Mesh:
Year: 2014 PMID: 25101264 PMCID: PMC4101231 DOI: 10.1155/2014/175398
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 2Late RT-related changes of the laryngopharyngeal mucosa. Note diffuse and regular distribution of IPCL.
Frequency of follow-up visits.
| Frequency of follow-up visits | Year of follow-up | |||
|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |
| Frequency of videoendoscopic evaluation | Every 3 months | Every 3 months | Every 4 months | Every 6 months |
| Frequency of follow-up visits (without NBI) | Every 6–8 weeks | Every 8–12 weeks | Every 4 months | Every 6 months |
Clinical characteristics of the study cohort.
| Demography | Patients number (%) |
|---|---|
| Age, mean, range | 62.6 yrs, 42–83 |
| Sex | |
| Male | 44 (66.7) |
| Female | 12 (33.3) |
| Primary tumor site | |
| Glottis | 56 (85) |
| T1 | 35 (62.5) |
| T2 | 14 (25) |
| T3 | 7 (12.5) |
| T4 | 0 (0) |
| Supraglottis | 5 (8.9) |
| T1 | 1 (20) |
| T2 | 2 (40) |
| T3 | 2 (40) |
| T4 | 0 (0) |
| Subglottis | 1 (1.8) |
| T1 | 1 (100) |
| Hypopharynx | 4 (7.1) |
| T1 | 1 (25) |
| T2 | 3 (75) |
| T3 | 0 (0) |
| T4 | 0 (0) |
| Prior surgery | |
| Yes | 13 (19.7) |
| No | 53 (80.3) |
Figure 3Appearance of the histologically proven invasive SCC, recurrence after RT.
Figure 4(a and b) Videoendoscopic aspect at the 6-month FU visit. (c and d) Close-up of the suspicious lesion on the surface of the right vocal cord.
True positive cases, characteristics.
| Number | Sex, age | Pretreatment T, site | Previous treatment | Histology | pT stage | Therapy |
|---|---|---|---|---|---|---|
| 1 | F, 64 | 2, G | RT | SCC | 3 | Endoscopy, waiting for surgery |
| 2 | M, 67 | 2, G | RT | SCC | 3 | LET |
| 3 | M, 64 | 1a, G | Endo., RT | SCC | 3 | LET |
| 4 | F, 62 | 3, G | Endo., RT | SCC | 3 | LET |
| 5 | M, 63 | 2, G | Endo., RT | SCC | 3 | LET |
| 6 | M, 56 | 1a, G | Endo., RT | SCC | 3 | FLLE |
| 7 | M, 56 | 1a, G | RT | Ca in situ | 1b | Laryngofissure |
| 8 | M, 63 | 1b, G | RT | SCC | 3 | LET |
| 9 | M, 52 | 1a, G | RT | SCC | 2 | Endo. |
| 10 | M, 52 | 1a, G | RT | SCC | 1a | Endo. |
| 11 | F, 60 | 1a, G | RT | SCC | 3 | LET |
| 12 | M, 71 | 1a, HP | RT | SCC | 1a | Endo. |
| 13 | M, 57 | 3, Sup. | RT | SCC | 4 | Waiting for surgery |
| 14 | M, 62 | 1b, G | RT | SCC | 3 | Died before planned surgery |
G: glottic, HP: hypopharynx, Sup.: supraglottic, SCC: squamous cell cancer, LET: total laryngectomy, and FLLE: frontolateral laryngectomy.
False positive cases, characteristics.
| Number | Sex, age | Pretreatment T, site | Previous treatment | FU to diagnosis | Histology |
|---|---|---|---|---|---|
| 1 | M, 66 | 1a, G | RT | Moderate dysplasia | |
| 2 | M, 42 | 1b, G | RT | Hyperkeratosis | |
| 3 | F, 42 | 1, S | RT | Chronic inflammation | |
| 4 | M, 57 | 1a, G | RT | Moderate dysplasia |
Figure 5Time to diagnosis of recurrence (X—months, Y—number of patients).
Sensitivity, specificity, positive (PPV) and negative (NPV) predictive value, and accuracy of the outpatient NBI videoendoscopy and WL and NBI magnifying endoscopy.
| Sensitivity (%) | Specificity (%) | Positive predictive value (%) | Negative predictive value (%) | Accuracy (%) | |
|---|---|---|---|---|---|
| Outpatient videoendoscopy with NBI | 88 | 92 | 76 | 96 | 91 |
| WL + NBI magnifying endoscopy | 100 | 92 | 79 | 100 | 94 |
Figure 1(a) SCC in WL examination. (b) NBI examination—well-demarcated brownish area with thick brown dots.